PD-020Tolerability and activity of second-line tepotinib, a potent and highly selective c-MET inhibitor, in patients with advanced hepatocellular carcinoma previously treated with sorafenib
| Image |  |
|---|---|
| Description | scientific article published on 21 June 2016 |
| Author/s |
author: Thomas Decaens Sandrine Faivre |
| Publication date | June 21, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |